FDA approves generic testosterone replacement gel - - UrologyTimes

ADVERTISEMENT

ADVERTISEMENT

ADVERTISEMENT

FDA approves generic testosterone replacement gel
Feb 2, 2006
Urology Times E-News

Watson Pharmaceuticals has received FDA approval on its abbreviated new drug application for a generic version of testosterone gel 1% CIII. The drug is indicated for replacement therapy in males for conditions associated with a deficiency or absence of endogenous testosterone.


ModernMedicine is an innovative new online resource
designed to meet the evolving needs of physicians, nurses
and other allied healthcare professionals.

Click here to visit ModernMedicine.com

ADVERTISEMENT

Urology Times issue
Stay connected to Urology Times
Receive new issue alerts, technology bulletins, and conference updates!

ADVERTISEMENT

EVENTS CALENDAR
American Urological Association Annual Review Course
July 09 - July 13
20th Annual Video Urology World Congress/18th Malaysian Urological Conference
July 24 - July 26
Certification Qualifying (Part 1) Exam
July 28 - July 29
AUA Best of the Annual Meeting: Cutting Edge Topics in Urology
August 07 - August 09
AUA Global Genitourinary Oncology
August 14 - August 15
What Do You Think?
Are more of your patients delaying or skipping care during the current recession?
Yes
No
Not Sure
Yes
81%
No
6%
Not Sure
13%
CME SHOWCASE
Updated guidelines for the management of ureteral calculi
Risk stratification in nonmuscle-invasive bladder cancer
Risk stratification in nonmuscle-invasive bladder cancer
Management of postoperative ileus
PIN or atypical foci suspicious for PCa on biopsy: Risks and recommendations

Modern Medicine logoUrology Times archives are now available on ModernMedicine.com, a new online resource designed to meet the evolving needs of physicians.
Register now (it's free and quick) or Find out more.

Keep visiting UrologyTimes.com for fresh content, news, opinions, editor's blogs and more.

ADVERTISEMENT

Modern Medicine is a new online resource designed to meet the evolving needs of physicians. It brings together elements from Advanstar's trusted healthcare journals along with powerful tools, resources, decision support and advisory functions.

Source: Urology Times E-News, 2/2/2006
Click here